デフォルト表紙
市場調査レポート
商品コード
1793440

羊痘・山羊痘ワクチンの世界市場レポート2025年

Sheep And Goat Pox Vaccines Global Market Report 2025

出版日
ページ情報
英文 250 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
羊痘・山羊痘ワクチンの世界市場レポート2025年
出版日: 2025年08月18日
発行: The Business Research Company
ページ情報: 英文 250 Pages
納期: 2～10営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

羊痘・山羊痘ワクチンの市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR4.2％で713億7,000万米ドルに成長します。予測期間の成長は、畜産物需要の増加、畜産業の拡大、ワクチンに対する政府補助金、獣医学研究への投資増加、ワクチン製造の技術進歩、動物の健康に対する意識の高まり、国際貿易協定、疾病パターンに影響を与える気候変動、新しいワクチン技術の出現、発展途上地域の経済成長に起因すると考えられます。予測期間における主な動向としては、多価ワクチンの開発、組み換えワクチンの使用増加、ワクチンの安全性への注目の高まり、官民パートナーシップの増加、動物用ワクチン市場の拡大、ワクチン接種プログラムのデジタル追跡、動物衛生研究への資金提供の増加、地域的な疾病撲滅イニシアティブ、持続可能な農業慣行の採用拡大、ワクチンに関する規制枠組みの強化などが挙げられます。

今後5年間の成長率4.2％という予測は、前回の予測から0.1％の微減を反映しています。この減少は主に米国と他国との間の関税の影響によるものです。ワクチンの有効性に不可欠なアジュバントや安定剤の関税による輸入遅延は、小型反芻動物の疾病予防結果に影響を及ぼす可能性があります。また、相互関税や、貿易摩擦・制限の激化による世界経済・貿易への悪影響により、その影響はより広範囲に及ぶと思われます。

畜産物に対する需要の高まりは、羊痘・山羊痘ワクチン市場の成長を牽引することになると思われます。畜産物には、農業環境で飼育された家畜に由来する様々な商品が含まれます。こうした需要の高まりは、所得や人口の増加、都市化、健康への配慮、消費者の嗜好の進化、世界化、貿易、経済開発などの要因に起因しています。羊痘・山羊痘ワクチンは、病気の発生を予防し、羊や山羊の個体群の健康と生産性を確保することで、畜産物を保護するという重要な役割を担っています。例えば、2024年2月、環境・食料・農村地域省は、赤身肉、特にマトンとラム肉の生産量の増加を指摘しており、最大の増加率は2.9％でした。さらに、2022年の国内魚類総生産量は41億8,200万トンをわずかに上回り、2020年の41億7,800万トンから増加しました。したがって、畜産物に対する需要の増大が羊痘・山羊痘ワクチン市場の拡大を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の羊痘・山羊痘ワクチン：PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
  • 最終用途産業の分析
  • 世界の羊痘・山羊痘ワクチン市場：成長率分析
  • 世界の羊痘・山羊痘ワクチン市場の実績：規模と成長, 2019-2024
  • 世界の羊痘・山羊痘ワクチン市場の予測：規模と成長, 2024-2029, 2034F
  • 世界の羊痘・山羊痘ワクチン：総潜在市場規模（TAM）

第6章 市場セグメンテーション

  • 世界の羊痘・山羊痘ワクチン市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 生弱毒化ワクチン
  • 不活化ワクチン
  • その他のタイプ
  • 世界の羊痘・山羊痘ワクチン市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 注射剤
  • 鼻腔内
  • 世界の羊痘・山羊痘ワクチン市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 羊
  • 山羊
  • 世界の羊痘・山羊痘ワクチン市場、生弱毒化ワクチン、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
  • 一価生弱毒化ワクチン
  • 多価生弱毒化ワクチン
  • 世界の羊痘・山羊痘ワクチン市場、不活化ワクチン、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
  • アジュバント添加不活化ワクチン
  • アジュバント不活化ワクチン
  • 世界の羊痘・山羊痘ワクチン市場、その他のタイプ、タイプ別サブセグメンテーション：実績と予測, 2019-2024, 2024-2029F, 2034F
  • 組み換えワクチン
  • DNAベースのワクチン

第7章 地域別・国別分析

  • 世界の羊痘・山羊痘ワクチン市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の羊痘・山羊痘ワクチン市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 羊痘・山羊痘ワクチン市場：競合情勢
  • 羊痘・山羊痘ワクチン市場：企業プロファイル
    • Indian Immunologicals Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Kemin Industries Overview, Products and Services, Strategy and Financial Analysis
    • Bimeda Biologicals Overview, Products and Services, Strategy and Financial Analysis
    • Hester Biosciences Limited Overview, Products and Services, Strategy and Financial Analysis
    • Dollvet Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • MSD Animal Health
  • MCI Sante Animale
  • Creative Biolabs
  • Biovex Inc.
  • Advacare Pharma
  • Brilliant Bio Pharma Private Limited
  • Intervac（PVT）Ltd.
  • Agrinnovate India Limited
  • Bio-Med Pvt Limited
  • JOVAC
  • Vetal Animal Health Products
  • Kenya Veterinary Vaccines Production Institute
  • Vedall Pharma Private Limited
  • Farmer's Pharma Private Limited
  • Institute of Veterinary Biological Products

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 羊痘・山羊痘ワクチン市場2029：新たな機会を提供する国
  • 羊痘・山羊痘ワクチン市場2029：新たな機会を提供するセグメント
  • 羊痘・山羊痘ワクチン市場2029：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31208u

Sheep and goat pox vaccines are specifically developed to prevent diseases caused by viruses belonging to the Capripoxvirus genus, which include sheep pox and goat pox. These vaccines play a critical role in preventing and managing outbreaks among sheep and goat populations, as both diseases can lead to significant economic losses due to high mortality rates and reduced productivity. They function by stimulating the immune system to generate antibodies against the viruses, thereby providing protection from infection.

The primary types of sheep and goat pox vaccines include live attenuated vaccines, inactivated vaccines, and others. Live attenuated vaccines use weakened forms of the virus to stimulate the immune system without causing severe illness. They are particularly effective for diseases such as sheep and goat pox where a robust immune response is necessary for effective protection. These vaccines are administered via various routes such as injectable and intranasal applications for sheep and goats.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The sheep and goat pox vaccines research report is one of a series of new reports from The Business Research Company that provides sheep and goat pox vaccines market statistics, including the sheep and goat pox vaccines industry's global market size, regional shares, competitors with a sheep and goat pox vaccines market share, detailed sheep and goat pox vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the sheep and goat pox vaccines industry. This sheep and goat pox vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The sheep and goat pox vaccines market size has grown steadily in recent years. It will grow from $57.79 billion in 2024 to $60.43 billion in 2025 at a compound annual growth rate (CAGR) of 4.6%. The growth in the historic period can be attributed to increased outbreaks of sheep and goat pox, government vaccination programs, advancements in veterinary medicine, high mortality rates in livestock, increased awareness among farmers, economic losses due to disease, trade restrictions on affected areas, improved diagnostic techniques, the historical prevalence of the disease, and collaboration between veterinary institutions.

The sheep and goat pox vaccines market size is expected to see steady growth in the next few years. It will grow to $71.37 billion in 2029 at a compound annual growth rate (CAGR) of 4.2%. The growth in the forecast period can be attributed to the growing demand for livestock products, expanding livestock farming, government subsidies for vaccines, rising investment in veterinary research, technological advancements in vaccine production, increasing awareness of animal health, international trade agreements, climate change impacting disease patterns, the emergence of new vaccine technologies, economic growth in developing regions. Major trends in the forecast period include the development of multivalent vaccines, increasing use of recombinant vaccines, growing focus on vaccine safety, rise in public-private partnerships, expansion of veterinary vaccine market, digital tracking of vaccination programs, increased funding for animal health research, regional disease eradication initiatives, growing adoption of sustainable farming practices, enhanced regulatory frameworks for vaccines.

The forecast of 4.2% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff-driven import delays in adjuvants and stabilizers essential for vaccine efficacy may affect disease prevention outcomes in small ruminants. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing demand for livestock products is poised to drive growth in the market for sheep and goat pox vaccines. Livestock products encompass various goods derived from domesticated animals raised in agricultural settings. This rising demand stems from factors such as income and population growth, urbanization, health considerations, evolving consumer preferences, globalization, trade, and economic development. Sheep and goat pox vaccines play a crucial role in protecting livestock products by preventing disease outbreaks and ensuring the health and productivity of sheep and goat populations. For example, in February 2024, the Department for Environment, Food, and Rural Affairs noted an increase in red meat production, particularly mutton and lamb, with the largest rise recorded at 2.9%. Additionally, total domestic fish production in 2022 slightly exceeded 4,182 million metric tons, up from 4,178 million metric tons in 2020. Hence, the growing demand for livestock products is expected to drive expansion in the sheep and goat pox vaccines market.

Major companies in the sheep and goat pox vaccine market are concentrating on the development of innovative products, such as live attenuated vaccines, to improve immune responses while minimizing side effects. Live attenuated vaccines contain live viruses or bacteria that have been weakened in the laboratory to prevent them from causing disease in healthy individuals. These vaccines stimulate a strong immune response by simulating a natural infection without causing illness. For example, in August 2022, the Indian Council of Agricultural Research, based in India, developed Lumpi-ProVacInd to fight Lumpy Skin Disease (LSD) in cattle. This vaccine is intended for preventive immunization, providing immunity for at least one year with a single dose that contains 103.5 TCID50 of the attenuated LSD virus. It is safe for animals, induces a strong immune response, and must be stored at 4°C, requiring careful handling during transportation and use.

In September 2022, Hester Biosciences Limited, an India-based animal healthcare company, acquired the manufacturing technology for the Goat Pox vaccine (Uttarkashi Strain) from the Indian Veterinary Research Institute (IVRI) for an undisclosed sum. This acquisition enables Hester to supply the goat pox vaccine through state government tenders for cattle immunization against lumpy skin disease in various states. The Indian Veterinary Research Institute, a prominent institution for livestock research and development in India, facilitated this technology transfer.

Major companies operating in the sheep and goat pox vaccines market are Indian Immunologicals Ltd., Kemin Industries, Bimeda Biologicals, Hester Biosciences Limited, Dollvet, MSD Animal Health, MCI Sante Animale, Creative Biolabs, Biovex Inc., Advacare Pharma, Brilliant Bio Pharma Private Limited, Intervac (PVT) Ltd., Agrinnovate India Limited, Bio-Med Pvt Limited, JOVAC, Vetal Animal Health Products, Kenya Veterinary Vaccines Production Institute, Vedall Pharma Private Limited, Farmer's Pharma Private Limited, Institute of Veterinary Biological Products

North America was the largest region in the sheep and goat pox vaccines market in 2024. The regions covered in the sheep and goat pox vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the sheep and goat pox vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sheep and goat pox vaccines market consists of sales of recombinant vaccines and subunit vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Sheep And Goat Pox Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sheep and goat pox vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sheep and goat pox vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sheep and goat pox vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Live Attenuated Vaccines; Inactivated Vaccines; Other Types
  • 2) By Route Of Administration: Injectable; Intranasal
  • 3) By Application: Sheep; Goat
  • Subsegments:
  • 1) By Live Attenuated Vaccines: Monovalent Live Attenuated Vaccines; Multivalent Live Attenuated Vaccines
  • 2) By Inactivated Vaccines: Adjuvanted Inactivated Vaccines; Non-Adjuvanted Inactivated Vaccines
  • 3) By Other Types: Recombinant Vaccines; DNA-Based Vaccines
  • Companies Mentioned: Indian Immunologicals Ltd.; Kemin Industries; Bimeda Biologicals; Hester Biosciences Limited; Dollvet; MSD Animal Health; MCI Sante Animale; Creative Biolabs; Biovex Inc.; Advacare Pharma; Brilliant Bio Pharma Private Limited; Intervac (PVT) Ltd.; Agrinnovate India Limited; Bio-Med Pvt Limited; JOVAC; Vetal Animal Health Products; Kenya Veterinary Vaccines Production Institute; Vedall Pharma Private Limited; Farmer's Pharma Private Limited; Institute of Veterinary Biological Products
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Sheep And Goat Pox Vaccines Market Characteristics

3. Sheep And Goat Pox Vaccines Market Trends And Strategies

4. Sheep And Goat Pox Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Sheep And Goat Pox Vaccines Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Sheep And Goat Pox Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Sheep And Goat Pox Vaccines Market Growth Rate Analysis
  • 5.4. Global Sheep And Goat Pox Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Sheep And Goat Pox Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Sheep And Goat Pox Vaccines Total Addressable Market (TAM)

6. Sheep And Goat Pox Vaccines Market Segmentation

  • 6.1. Global Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Other Types
  • 6.2. Global Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Injectable
  • Intranasal
  • 6.3. Global Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sheep
  • Goat
  • 6.4. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monovalent Live Attenuated Vaccines
  • Multivalent Live Attenuated Vaccines
  • 6.5. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adjuvanted Inactivated Vaccines
  • Non-Adjuvanted Inactivated Vaccines
  • 6.6. Global Sheep And Goat Pox Vaccines Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Recombinant Vaccines
  • DNA-Based Vaccines

7. Sheep And Goat Pox Vaccines Market Regional And Country Analysis

  • 7.1. Global Sheep And Goat Pox Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Sheep And Goat Pox Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Sheep And Goat Pox Vaccines Market

  • 8.1. Asia-Pacific Sheep And Goat Pox Vaccines Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Sheep And Goat Pox Vaccines Market

  • 9.1. China Sheep And Goat Pox Vaccines Market Overview
  • 9.2. China Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Sheep And Goat Pox Vaccines Market

  • 10.1. India Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Sheep And Goat Pox Vaccines Market

  • 11.1. Japan Sheep And Goat Pox Vaccines Market Overview
  • 11.2. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Sheep And Goat Pox Vaccines Market

  • 12.1. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Sheep And Goat Pox Vaccines Market

  • 13.1. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Sheep And Goat Pox Vaccines Market

  • 14.1. South Korea Sheep And Goat Pox Vaccines Market Overview
  • 14.2. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Sheep And Goat Pox Vaccines Market

  • 15.1. Western Europe Sheep And Goat Pox Vaccines Market Overview
  • 15.2. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Sheep And Goat Pox Vaccines Market

  • 16.1. UK Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Sheep And Goat Pox Vaccines Market

  • 17.1. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Sheep And Goat Pox Vaccines Market

  • 18.1. France Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Sheep And Goat Pox Vaccines Market

  • 19.1. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Sheep And Goat Pox Vaccines Market

  • 20.1. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Sheep And Goat Pox Vaccines Market

  • 21.1. Eastern Europe Sheep And Goat Pox Vaccines Market Overview
  • 21.2. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Sheep And Goat Pox Vaccines Market

  • 22.1. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Sheep And Goat Pox Vaccines Market

  • 23.1. North America Sheep And Goat Pox Vaccines Market Overview
  • 23.2. North America Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Sheep And Goat Pox Vaccines Market

  • 24.1. USA Sheep And Goat Pox Vaccines Market Overview
  • 24.2. USA Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Sheep And Goat Pox Vaccines Market

  • 25.1. Canada Sheep And Goat Pox Vaccines Market Overview
  • 25.2. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Sheep And Goat Pox Vaccines Market

  • 26.1. South America Sheep And Goat Pox Vaccines Market Overview
  • 26.2. South America Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Sheep And Goat Pox Vaccines Market

  • 27.1. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Sheep And Goat Pox Vaccines Market

  • 28.1. Middle East Sheep And Goat Pox Vaccines Market Overview
  • 28.2. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Sheep And Goat Pox Vaccines Market

  • 29.1. Africa Sheep And Goat Pox Vaccines Market Overview
  • 29.2. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Sheep And Goat Pox Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Sheep And Goat Pox Vaccines Market Competitive Landscape And Company Profiles

  • 30.1. Sheep And Goat Pox Vaccines Market Competitive Landscape
  • 30.2. Sheep And Goat Pox Vaccines Market Company Profiles
    • 30.2.1. Indian Immunologicals Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Kemin Industries Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Bimeda Biologicals Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Hester Biosciences Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Dollvet Overview, Products and Services, Strategy and Financial Analysis

31. Sheep And Goat Pox Vaccines Market Other Major And Innovative Companies

  • 31.1. MSD Animal Health
  • 31.2. MCI Sante Animale
  • 31.3. Creative Biolabs
  • 31.4. Biovex Inc.
  • 31.5. Advacare Pharma
  • 31.6. Brilliant Bio Pharma Private Limited
  • 31.7. Intervac (PVT) Ltd.
  • 31.8. Agrinnovate India Limited
  • 31.9. Bio-Med Pvt Limited
  • 31.10. JOVAC
  • 31.11. Vetal Animal Health Products
  • 31.12. Kenya Veterinary Vaccines Production Institute
  • 31.13. Vedall Pharma Private Limited
  • 31.14. Farmer's Pharma Private Limited
  • 31.15. Institute of Veterinary Biological Products

32. Global Sheep And Goat Pox Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Sheep And Goat Pox Vaccines Market

34. Recent Developments In The Sheep And Goat Pox Vaccines Market

35. Sheep And Goat Pox Vaccines Market High Potential Countries, Segments and Strategies

  • 35.1 Sheep And Goat Pox Vaccines Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Sheep And Goat Pox Vaccines Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Sheep And Goat Pox Vaccines Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer